GL1X · GenesisL1 explorer

Research workbench

Cryo-EM structure of adna-ADNB(W325A) in complex with DNA and amppnp

Analyse Cryo-EM structure of adna-ADNB(W325A) in complex with DNA and amppnp in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7SJR
Type
protein + DNA
Length
1,748 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA helicase; DNA (70-mer)
EC
3.6.4.12
UniProt
A0A653FJ17, A0A0D6HKQ2
Ligands
SF4, ANP, MG
Pockets
20 · best druggability 0.82

Structure

electron microscopy · 3 distinct chains · 46% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BDNA helicase (EC 3.6.4.12)protein80245% helix, 6% strandA0A653FJ17
ADNA helicase (EC 3.6.4.12)protein91147% helix, 8% strandA0A0D6HKQ2
CDNA (70-mer)dna35——

Ligands and binding sites

  • SF4 · Iron/sulfur cluster · ligand · chains A
  • ANP · Phosphoaminophosphonic acid-adenylate ester · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 18 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111930.820.84128empty
29440.790.8178empty
311050.750.77113ANP
44770.730.8259empty
55000.720.8244empty

Interfaces

3 interfaces between chains.

  • B–A · 6494 Ų buried · 42 hydrogen bonds · protein-protein
  • B–C · 1450 Ų buried · 19 hydrogen bonds · protein-nucleic
  • A–C · 643 Ų buried · 8 hydrogen bonds · protein-nucleic

Compared structures

  • 7SJR · Cryo-EM structure of AdnA-AdnB(W325A) in complex with DNA and AMPPNP · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.